$AIP

Hawkins Nicholas B. sold $209K of AIP

Hawkins Nicholas B. (VP and Chief Financial Officer) sold 5,377 shares of Arteris, Inc. (AIP) at $38.78 ($0.21M total) across 4 trades on 2026-07-02.

Original reporting
SEC EDGAR · Hawkins Nicholas B.
Published Jul 6, 2026, 9:24 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 6, 2026, 9:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AIP
Neutral
medium confidence
Mentioned
$AIP
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPNeutralLow
01

Why it matters

The newest fact is the CFO’s open-market sale details (5,377 shares at ~$38.7779; ~$208.5K total) and the post-transaction holdings (103,172 shares).

02

Market read

Traders may monitor for follow-on insider activity, but this disclosure alone does not change fundamentals.

03

What to watch

Insider sales can be routine compensation/tax-related; without additional filings (other insiders, buybacks, guidance), the signal is weak.

Relevance 4/10Novelty 3/10Timing: new SEC Form 4 filed July 6 (covers July 2 sales)

Background

The article is a primary-source SEC Form 4 insider transaction for Arteris, Inc. (AIP).

Company-level read

Ticker impact

$AIPNeutralMedium confidence
Context

Arteris CFO Nicholas Hawkins sold $208,508 of AIP shares in open-market trades on July 2, per a new SEC Form 4 filing.

Expected impact

Likely minimal near-term price impact; any effect is sentiment-driven and should fade unless more disclosures follow.

Evidence & confidence

The filing provides transaction size, price, and post-sale holdings, but no accompanying company-specific catalyst (earnings, guidance, deal, or regulatory action).

Market effects

No clear sector read-through; insider sales are company-specific and often non-informational.

None indicated.

None indicated.

Counterpoint

The absence of a disclosed 10b5-1 plan could be interpreted as more discretionary selling, but the article provides no context (taxes, diversification, planned liquidity needs).

Key entities

  • Arteris, Inc.

    Subject of the Form 4 insider sale by its CFO.

  • Nicholas B. Hawkins

    VP and Chief Financial Officer who sold shares in open-market trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIPMedAI 8/10

Arteris (AIP) Q2 2026 Earnings Call Transcript

Arteris, Inc. (AIP) reported Q2 2026 revenue of $24.1 million, up 46% year over year. ACV plus royalties were $99.5 million, up 44%, and remaining performance obligation was $135 million, up 36%. Cash and investments rose to $123 million after an at-the-market raise. Full-year 2026 revenue guidance was raised to $95-$98 million.

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, to